Paperback. Condizione: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. 1st edition NO-PA16APR2015-KAP.
Da: Majestic Books, Hounslow, Regno Unito
EUR 57,05
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 57,89
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
EUR 64,95
Quantità: 2 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Condizione: NEW.
Lingua: Inglese
Editore: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 76,21
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 59,77
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Taylor & Francis Ltd, London, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Paperback. Condizione: new. Paperback. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD. This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Lingua: Inglese
Editore: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Da: Rarewaves USA, OSWEGO, IL, U.S.A.
Paperback. Condizione: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 69,71
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Chiron Media, Wallingford, Regno Unito
EUR 64,81
Quantità: 2 disponibili
Aggiungi al carrellopaperback. Condizione: New.
EUR 72,95
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 67,86
Quantità: 1 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 68,39
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Revaluation Books, Exeter, Regno Unito
EUR 79,38
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 192 pages. 10.00x7.00x1.18 inches. In Stock.
Condizione: New.
EUR 59,78
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: NEW.
Lingua: Inglese
Editore: Taylor & Francis Ltd, London, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Da: CitiRetail, Stevenage, Regno Unito
EUR 72,60
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: new. Paperback. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD. This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
EUR 69,86
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Da: Rarewaves USA United, OSWEGO, IL, U.S.A.
Paperback. Condizione: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.
Lingua: Inglese
Editore: Taylor & Francis Ltd Sep 2024, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 73,98
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware - This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.
Lingua: Inglese
Editore: Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032170239 ISBN 13: 9781032170237
Da: Rarewaves.com UK, London, Regno Unito
EUR 71,37
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: New. Chronic obstructive pulmonary disease is, of 2024, one of the three main causes of death in the world, affecting around 12% of the world's population. Its incidence is estimated to increase in the coming decades due to continuous exposure to risk factors and to an aging population.Pulmonary emphysema is one of its most serious phenotypes, with chronic and inexorable progression and, in the most severe stages, it is highly disabling and lethal.This book reviews knowledge about the pathophysiology of severe pulmonary emphysema and the current innovative interventional and minimally invasive therapeutic concepts for the management of these advanced stages of emphysema, based on the best scientific evidence.This guide provides to multidisciplinary pulmonary boards of experts in advanced lung diseases, current criteria for the choice of precision therapeutic options and beyond to maintaining optimized medical treatment to controlling lung hyperinflation, and alleviating patients' symptoms.This book is a valuable resource for clinicians dealing with critically ill patients with COPD.